Correction: The association between hemoglobin level and sarcopenia in Chinese patients with Crohn ’s disease
(Source: BMC Gastroenterology)
Source: BMC Gastroenterology - March 19, 2024 Category: Gastroenterology Authors: Nandong Hu, Jingjing Liu, Xifa Gao, Hongye Tang, Jiangchuan Wang, Zicheng Wei, Zhongqiu Wang, Xiaoli Yu and Xiao Chen Tags: Correction Source Type: research
Infantile inflammatory bowel disease in three Syrian infants: a case series
ConclusionsEarly diagnosis and ruling out infantile inflammatory bowel diseases despite its rarity are recommended. Over and above that, new drugs such as vedolizumab, golimumab, and less invasive treatment methods should also be taken into consideration for better response and adequate remission with improved quality of life. (Source: Journal of Medical Case Reports)
Source: Journal of Medical Case Reports - March 18, 2024 Category: General Medicine Source Type: research
Comparative Efficacy of Subcutaneous and Intravenous Infliximab and Vedolizumab for Maintenance Treatment of TNF-naive Adult Patients with Inflammatory Bowel Disease: A Systematic Literature Review and Network Meta-analysis
ConclusionsSubcutaneous infliximab showed a favorable efficacy profile for achieving clinical remission and endoscopic outcomes during maintenance treatment in CD or UC.Graphical Abstract (Source: Digestive Diseases and Sciences)
Source: Digestive Diseases and Sciences - March 18, 2024 Category: Gastroenterology Source Type: research
Correction: Increased CpG methylation at the CDH1 locus in inflamed ileal mucosa of patients with Crohn disease
(Source: Clinical Epigenetics)
Source: Clinical Epigenetics - March 18, 2024 Category: Research Authors: Charles de Ponthaud, Solafah Abdalla, Marie-Pierre Belot, Xiaojian Shao, Christophe Penna, Antoine Brouquet and Pierre Bougn ères Tags: Correction Source Type: research
Comparative Efficacy of Subcutaneous and Intravenous Infliximab and Vedolizumab for Maintenance Treatment of TNF-naive Adult Patients with Inflammatory Bowel Disease: A Systematic Literature Review and Network Meta-analysis
ConclusionsSubcutaneous infliximab showed a favorable efficacy profile for achieving clinical remission and endoscopic outcomes during maintenance treatment in CD or UC.Graphical Abstract (Source: Digestive Diseases and Sciences)
Source: Digestive Diseases and Sciences - March 18, 2024 Category: Gastroenterology Source Type: research
Prognosis of Patients with Crohn's Disease and Ulcerative Colitis Following Percutaneous Coronary Intervention Procedures
CONCLUSIONS: We observed higher rates of TLF in IBD patients compared to the general population as well as differences in clinical outcomes between UC and CD patients. A better understanding of the prognostic factors and pathophysiology of these differences may have clinical importance in tailoring the appropriate treatment or type of revascularization for this high-risk group.PMID:38493327 (Source: The Israel Medical Association Journal)
Source: The Israel Medical Association Journal - March 17, 2024 Category: General Medicine Authors: Jill Savren Lotker Ariel Roguin Arthur Kerner Erez Marcusohn Ofer Kobo Source Type: research
Sophoricoside improved Crohn's disease-like colitis by inhibiting intestinal epithelial cell apoptosis through PI3K/AKT signaling
CONCLUSIONS: SOP can reduce IECs apoptosis through the inhibition of the PI3K/AKT signaling pathway, thereby protecting the intestinal barrier. This study is the first to illustrate how SOP ameliorates colitis and protects the intestinal barrier, suggesting SOP has potential clinical application in treating CD.PMID:38493691 | DOI:10.1016/j.intimp.2024.111886 (Source: International Immunopharmacology)
Source: International Immunopharmacology - March 17, 2024 Category: Allergy & Immunology Authors: Qingqing Li Jing Li Lixia Yin Ju Huang Xinyue Liu Jinran Shi Zhijun Geng Xue Song Lian Wang Yueyue Wang Xiaofeng Zhang Lugen Zuo Jianguo Hu Source Type: research
Prognosis of Patients with Crohn's Disease and Ulcerative Colitis Following Percutaneous Coronary Intervention Procedures
CONCLUSIONS: We observed higher rates of TLF in IBD patients compared to the general population as well as differences in clinical outcomes between UC and CD patients. A better understanding of the prognostic factors and pathophysiology of these differences may have clinical importance in tailoring the appropriate treatment or type of revascularization for this high-risk group.PMID:38493327 (Source: The Israel Medical Association Journal)
Source: The Israel Medical Association Journal - March 17, 2024 Category: General Medicine Authors: Jill Savren Lotker Ariel Roguin Arthur Kerner Erez Marcusohn Ofer Kobo Source Type: research
